118 related articles for article (PubMed ID: 20477943)
1. RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors.
Celver J; Sharma M; Kovoor A
J Neurochem; 2010 Aug; 114(3):739-49. PubMed ID: 20477943
[TBL] [Abstract][Full Text] [Related]
2. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Kovoor A; Seyffarth P; Ebert J; Barghshoon S; Chen CK; Schwarz S; Axelrod JD; Cheyette BN; Simon MI; Lester HA; Schwarz J
J Neurosci; 2005 Feb; 25(8):2157-65. PubMed ID: 15728856
[TBL] [Abstract][Full Text] [Related]
3. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
[TBL] [Abstract][Full Text] [Related]
4. RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons.
Cabrera-Vera TM; Hernandez S; Earls LR; Medkova M; Sundgren-Andersson AK; Surmeier DJ; Hamm HE
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16339-44. PubMed ID: 15534226
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular composition dictates receptor and G protein selectivity of regulator of G protein signaling (RGS) 7 and 9-2 protein complexes in living cells.
Masuho I; Xie K; Martemyanov KA
J Biol Chem; 2013 Aug; 288(35):25129-25142. PubMed ID: 23857581
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
[TBL] [Abstract][Full Text] [Related]
7. D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions.
Celver J; Sharma M; Kovoor A
J Neurochem; 2012 Jan; 120(1):56-69. PubMed ID: 22035199
[TBL] [Abstract][Full Text] [Related]
8. Agonist-dependent internalization of D2 receptors: Imaging quantification by confocal microscopy.
Goggi JL; Sardini A; Egerton A; Strange PG; Grasby PM
Synapse; 2007 Apr; 61(4):231-41. PubMed ID: 17230553
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
Taymans JM; Kia HK; Claes R; Cruz C; Leysen J; Langlois X
Eur J Neurosci; 2004 Apr; 19(8):2249-60. PubMed ID: 15090051
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the regulator of G protein signaling RGS9 protein in nociceptive pathways of different age rats.
Kim KJ; Moriyama K; Han KR; Sharma M; Han X; Xie GX; Palmer PP
Brain Res Dev Brain Res; 2005 Nov; 160(1):28-39. PubMed ID: 16153714
[TBL] [Abstract][Full Text] [Related]
11. RGS4 exerts inhibitory activities on the signaling of dopamine D2 receptor and D3 receptor through the N-terminal region.
Min C; Cheong SY; Cheong SJ; Kim M; Cho DI; Kim KM
Pharmacol Res; 2012 Feb; 65(2):213-20. PubMed ID: 21896332
[TBL] [Abstract][Full Text] [Related]
12. RGS9 modulates dopamine signaling in the basal ganglia.
Rahman Z; Schwarz J; Gold SJ; Zachariou V; Wein MN; Choi KH; Kovoor A; Chen CK; DiLeone RJ; Schwarz SC; Selley DE; Sim-Selley LJ; Barrot M; Luedtke RR; Self D; Neve RL; Lester HA; Simon MI; Nestler EJ
Neuron; 2003 Jun; 38(6):941-52. PubMed ID: 12818179
[TBL] [Abstract][Full Text] [Related]
13. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
14. The membrane anchor R7BP controls the proteolytic stability of the striatal specific RGS protein, RGS9-2.
Anderson GR; Semenov A; Song JH; Martemyanov KA
J Biol Chem; 2007 Feb; 282(7):4772-4781. PubMed ID: 17158100
[TBL] [Abstract][Full Text] [Related]
15. Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.
Gaspari S; Papachatzaki MM; Koo JW; Carr FB; Tsimpanouli ME; Stergiou E; Bagot RC; Ferguson D; Mouzon E; Chakravarty S; Deisseroth K; Lobo MK; Zachariou V
Neuropsychopharmacology; 2014 Jul; 39(8):1968-77. PubMed ID: 24561386
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
17. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain.
Seeman P; Ko F; Jack E; Greenstein R; Dean B
Synapse; 2007 May; 61(5):303-9. PubMed ID: 17318883
[TBL] [Abstract][Full Text] [Related]
18. Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum.
Centonze D; Gubellini P; Usiello A; Rossi S; Tscherter A; Bracci E; Erbs E; Tognazzi N; Bernardi G; Pisani A; Calabresi P; Borrelli E
Neuroscience; 2004; 129(1):157-66. PubMed ID: 15489038
[TBL] [Abstract][Full Text] [Related]
19. Measuring the modulatory effects of RGS proteins on GIRK channels.
Doupnik CA; Jaén C; Zhang Q
Methods Enzymol; 2004; 389():131-54. PubMed ID: 15313564
[TBL] [Abstract][Full Text] [Related]
20. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
Wang JQ; McGinty JF
J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
